Scholars Central

Conference abstractPublished 29 Sep 2016

Indoxyl sulfate: A new link between chronic kidney disease and coagulation disorders in CKD patients on conservative treatment

Authors: Kaminski T, Karbowska M, Pawlak K, Myśliwiec M, Pawlak D

Medical University of Bialystok, Poland

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Objectives: Patients with chronic kidney disease (CKD) are at higher risk of incidence of thromboembolic events. The effect of continuous loss of function of nephrons is a progressive accumulation of uremic toxins. Indoxyl sulfate (IS) is an aggressive uremic toxin exerting proinflammatory and prooxidative properties, which affects multiple signaling pathways. Aim: We examined the association between indoxyl sulfate and activation of the coagulation system in predialysis patients with CKD. Methods: Studies have been conducted on a group of 53 patients with CKD on conservative treatment and 18 healthy volunteers. For the determination of parameters of coagulation ELISA-immuno-enzymatic kits were used, whereas the IS levels were determined by HPLC. The hematological and biochemical parameters were assessed using standard laboratory methods. Results: IS concentration was about three-fold higher in CKD patients compared to controls (p<0,0001). Parameters of coagulation: Von Willebrand factor (vWF), thrombomodulin (TM), tissue factor (TF) and its inhibitor-tissue factor pathway inhibitor (TFPI), prothrombin fragment 1+2 (F1+2) in uremic group were significantly higher than in control group (all p<0,0001). IS levels were positively correlated both with CKD markers and all mentioned above coagulation factors, and these results were also statistically significant (all p<0,0001, râÂ?¥0,45). Moreover, we found inverse correlation between IS and some hematological parameters (HCT, HGB, WBC, LIM and RBC). Conclusions: The results demonstrate a strong relationship between indoxyl sulfate and coagulation parameters in CKD patients. It opens a new idea that IS can play a crucial role in the occurrence of thromboembolic events in CKD patients.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Nephrology & Therapeutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Nephrology & Therapeutics
  • SubjectNephrology & Urology
  • BylineArticles whose byline prints “Kaminski T”
  • BylineArticles whose byline prints “Karbowska M”
  • BylineArticles whose byline prints “Pawlak K”
  • BylineArticles whose byline prints “Myśliwiec M”
  • BylineArticles whose byline prints “Pawlak D”